SENSUS HEALTHCARE DL-01
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for tr… Read more
SENSUS HEALTHCARE DL-01 (5TX) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, SENSUS HEALTHCARE DL-01 (5TX) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SENSUS HEALTHCARE DL-01 - Net Assets Trend (None–None)
This chart illustrates how SENSUS HEALTHCARE DL-01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SENSUS HEALTHCARE DL-01 (None–None)
The table below shows the annual net assets of SENSUS HEALTHCARE DL-01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SENSUS HEALTHCARE DL-01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SENSUS HEALTHCARE DL-01 Competitors by Market Cap
The table below lists competitors of SENSUS HEALTHCARE DL-01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aniplus Inc
KQ:310200
|
$47.19 Million |
|
KORE POTASH PLC DL-001
F:KP10
|
$47.19 Million |
|
Ajisen (China) Holdings Limited
F:AJN
|
$47.20 Million |
|
Gandhar Oil Refinery (India) Limited
NSE:GANDHAR
|
$47.21 Million |
|
KS Bancorp Inc
PINK:KSBI
|
$47.17 Million |
|
Akasha Wira International Tbk
JK:ADES
|
$47.17 Million |
|
Cinclus Pharma
ST:CINPHA
|
$47.17 Million |
|
ZOO BERLIN N M AQ
BE:ZOO
|
$47.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SENSUS HEALTHCARE DL-01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SENSUS HEALTHCARE DL-01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SENSUS HEALTHCARE DL-01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SENSUS HEALTHCARE DL-01's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SENSUS HEALTHCARE DL-01 (5TX) | €- | N/A | N/A | $47.18 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |